Psi-DOM

From WikiMD's WELLNESSPEDIA

Psi-DOM is a psychedelic drug that is similar in structure to mescaline and DOM. It was first synthesized by Alexander Shulgin and described in his book PiHKAL.

History[edit]

Psi-DOM was first synthesized by Alexander Shulgin, a renowned chemist and psychopharmacologist. Shulgin's work in the field of psychedelic research led to the discovery and synthesis of many new substances, including Psi-DOM. His findings were published in his book PiHKAL, which stands for Phenethylamines I Have Known And Loved.

Chemistry[edit]

Psi-DOM is a phenethylamine derivative and is structurally similar to other psychedelic drugs such as mescaline and DOM. It is part of the DOx family of compounds, which are known for their potent psychedelic effects.

Pharmacology[edit]

Like other psychedelic drugs, Psi-DOM is thought to exert its effects primarily through interaction with the serotonin system in the brain. It is believed to act as an agonist at the 5-HT2A receptor, which is involved in the regulation of mood, anxiety, and perception.

Effects[edit]

The effects of Psi-DOM are similar to those of other psychedelic drugs. These can include alterations in perception, mood, and thought, as well as physical effects such as increased heart rate and blood pressure. The duration of effects is typically longer than that of many other psychedelics, lasting up to 16 hours in some cases.

Legal status[edit]

The legal status of Psi-DOM varies by country. In many places, it is considered a controlled substance and its possession, manufacture, or distribution may be illegal.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.